Shake Shack has brought in three new executives. And the New York-based chain said CMO Jay Livingston has announced plans to leave the company in March to pursue new opportunities. Livingston, who has ...
Maze Therapeutics, a clinical-stage biopharmaceutical company, launched its initial public offering (IPO) today, with shares ...
Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million. The muted market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback